GB0618725D0 - Composition containing inhibitors of gastro-intestinal lipase - Google Patents

Composition containing inhibitors of gastro-intestinal lipase

Info

Publication number
GB0618725D0
GB0618725D0 GBGB0618725.6A GB0618725A GB0618725D0 GB 0618725 D0 GB0618725 D0 GB 0618725D0 GB 0618725 A GB0618725 A GB 0618725A GB 0618725 D0 GB0618725 D0 GB 0618725D0
Authority
GB
United Kingdom
Prior art keywords
gastro
composition containing
containing inhibitors
intestinal lipase
lipase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0618725.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Priority to GBGB0618725.6A priority Critical patent/GB0618725D0/en
Publication of GB0618725D0 publication Critical patent/GB0618725D0/en
Priority to PCT/EP2007/007835 priority patent/WO2008034533A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0618725.6A 2006-09-23 2006-09-23 Composition containing inhibitors of gastro-intestinal lipase Ceased GB0618725D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0618725.6A GB0618725D0 (en) 2006-09-23 2006-09-23 Composition containing inhibitors of gastro-intestinal lipase
PCT/EP2007/007835 WO2008034533A1 (en) 2006-09-23 2007-09-07 Compositions containing inhibitors of gastro-intestinal lipase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0618725.6A GB0618725D0 (en) 2006-09-23 2006-09-23 Composition containing inhibitors of gastro-intestinal lipase

Publications (1)

Publication Number Publication Date
GB0618725D0 true GB0618725D0 (en) 2006-11-01

Family

ID=37421470

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0618725.6A Ceased GB0618725D0 (en) 2006-09-23 2006-09-23 Composition containing inhibitors of gastro-intestinal lipase

Country Status (2)

Country Link
GB (1) GB0618725D0 (en)
WO (1) WO2008034533A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ510311A (en) * 1998-09-08 2003-08-29 Smithkline Beecham Corp Lipstatin derivative - soluble fiber tablets
SI1307264T1 (en) * 2000-07-28 2005-02-28 F. Hoffmann-La Roche Ag New pharmaceutical composition
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
DE60330764D1 (en) * 2002-04-26 2010-02-11 Hoffmann La Roche PHARMACEUTICAL COMPOSITION CONTAINING A LIPASE INHIBITOR AND GLUCOMANNAN

Also Published As

Publication number Publication date
WO2008034533A1 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
ZA200808282B (en) Uses of DPP-IV inhibitors
IL232786A0 (en) Inhibitors of e1 activating enzyme
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
ZA200807135B (en) Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
IL197869A0 (en) Compositions of chk1 inhibitors
HK1200440A1 (en) Crystalline forms of inhibitor
ZA201000318B (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
HK1129298A1 (en) Dihydrodiazepines useful as inhibitors of protein kinases
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
ZA200809873B (en) Inhibitors of c-fms kinase
EP2026843A4 (en) Therapeutic uses of inhibitors of rtp801l
IL197548A0 (en) Timing aspects of media content rendering
EP2054056A4 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
IL194699A0 (en) Tetrahydropteridines useful as inhibitors of protein kinases
GB0622084D0 (en) Inhibitors of HSP90
EP2007383A4 (en) Inhibitors of protein prenyltransferases
EP2054397A4 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
HK1131127A1 (en) Binding inhibitor of sphingosine-1-phosphate
ZA200806871B (en) Dihydrodiazepines useful as inhibitors of protein kinases
EP2018443A4 (en) Compositions and methods for inhibiting expression of ikk-b gene
HUP0600482A2 (en) Composition of additives
GB0618725D0 (en) Composition containing inhibitors of gastro-intestinal lipase
GB0519470D0 (en) Composition containing inhibitors of gastro-intestinal lipase
PL2035379T3 (en) Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)